Optimizing Linezolid Dosing by Renal Function: A Population Pharmacokinetic Study.
Objectives: Linezolid is administered at a fixed dose of 600 mg twice daily for the treatment of Gram‐positive infections. However, recent population pharmacokinetic studies reveal considerable interpatient variability, resulting in subtherapeutic or supratherapeutic drug exposures. This study aimed...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 2026; pp. 1 - 10 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , |
| Formato: | equations & formulas research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
3/24/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |